Biomerica Q1 EPS $(0.07) Up From $(0.16) YoY, Sales $1.71M Up From $1.64M YoY
Portfolio Pulse from Benzinga Newsdesk
Biomerica (NASDAQ:BMRA) reported Q1 losses of $(0.07) per share, a 56.25% improvement from $(0.16) per share YoY. Sales also increased by 4.64% to $1.71 million from $1.64 million YoY.
October 13, 2023 | 10:41 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biomerica's Q1 results show a significant improvement in losses per share and a slight increase in sales YoY.
The reported earnings show a significant improvement in losses per share, which is a positive sign for investors. The slight increase in sales also indicates a positive trend. These factors could potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100